Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) ...Middle East

WALTHAM, Mass., April 7, 2023 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 3, 2023 the Company granted inducement awards to purchase up to...

Hence then, the article about syndax pharmaceuticals reports inducement grants under nasdaq listing rule 5635 c 4 was published today ( Friday 07/04/2023 - 11:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) )

Also on site :

• ‘Seekers Of Infinite Love’ Review: Hannah Einbinder and Justin Theroux Star In Smart Cult Comedy That’s Worthy Of A Cult Of Its Own – SXSW
• The U.S. Mint just dropped the olive branch from the dime. What does that mean for the country?
• Remembering the 17 victims of Dunblane tragedy on 30th anniversary of the massacre that shocked the country